Evidence map›Paper›PMID 27242264›Full record

ArticleChemical communications (Cambridge, England)2016

Creating a hyperpolarised pseudo singlet state through polarisation transfer from parahydrogen under SABRE.

Alexandra M Olaru, Soumya S Roy, Lyrelle S Lloyd, Steven Coombes, Gary G R Green, Simon B Duckett

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Parahydrogen-Induced Hyperpolarization of Gases.Angewandte Chemie (International ed. in English) · 2020
    Review
  3. Review
  4. Article
  5. Long-LivedThe journal of physical chemistry letters · 2017
    Article
  6. Article
  7. NMR SLIC Sensing of Hydrogenation Reactions Using Parahydrogen in Low Magnetic Fields.The journal of physical chemistry. C, Nanomaterials and interfaces · 2016
    Article
  8. Using signal amplification by reversible exchange (SABRE) to hyperpolariseChemical communications (Cambridge, England) · 2016
    Article
  9. A HyperpolarizableAngewandte Chemie (International ed. in English) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandra M OlaruDepartment of Chemistry, University of York, Heslington, York YO10 5DD, UK. simon.duckett@york.ac.uk.
Soumya S RoyDepartment of Chemistry, University of York, Heslington, York YO10 5DD, UK. simon.duckett@york.ac.uk.
Lyrelle S LloydDepartment of Chemistry, University of York, Heslington, York YO10 5DD, UK. simon.duckett@york.ac.uk.
Steven CoombesAstraZeneca R&D Pharmaceutical Development, Silk Road Business Park, Charter Way, Macclesfield, Cheshire SK10 2NA, UK.
Gary G R GreenYork Neuroimaging Centre, The Biocentre, York Science Park, Innovation Way, Heslington, York YO10 5DD, UK.
Simon B DuckettDepartment of Chemistry, University of York, Heslington, York YO10 5DD, UK. simon.duckett@york.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The creation of magnetic states that have long lifetimes has been the subject of intense investigation, in part because of their potential to survive the time taken to travel from the point of injection in a patient to the point where a clinically diagnostic MRI trace is collected. We show here that it is possible to harness the signal amplification by reversible exchange (SABRE) process to create such states in a hyperpolarised form that improves their detectability in seconds without the need for any chemical change by reference to the model substrate 2-aminothiazole. We achieve this by transferring Zeeman derived polarisation that is 1500 times larger than that normally available at 400 MHz with greater than 90% efficiency into the new state, which in this case has a 27 second lifetime.

Identifiers

PMID27242264
PMCPMC5159739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.